Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Discussioni nella community
Non ci sono ancora discussioni su questo asset.
Avvia discussioneNotizie Vai al feed delle notizie
S&P raises Georgia Capital's credit rating to BB with stable outlook
S&P Global Ratings has raised Georgia Capital's credit rating from BB- to BB and set the outlook to stable. S&P cited balanced fiscal policy, ongoing debt reduction and sustainable shareholder returns as reasons for the decision. The rating matches Georgia's sovereign rating and applies to JSC Georgia Capital's foreign- and local-currency obligations. Georgia Capital holds, among other assets, a 16.6% stake in Lion Finance Group PLC. » Altro su de.investing.com
Georgia Capital sells residential development business m2 to local investors
Georgia Capital is selling the residential development business m2 to local investors in line with its capital-light strategy. The sale has a slightly positive effect on NAV as of 31 March 2026 and allows the target liquidity buffer to be reduced to USD 25m. Proceeds will be used to repay a USD 25m bond, lifting the pro-forma net cash-to-capital ratio as of 31 March 2026 to 3.1% (up 0.8 percentage points). » Altro su de.investing.com
Georgia Capital: portfolio-EBITDA rises 27% in Q1 2026 and NAV up 9.2% year-to-date
Georgia Capital reports aggregated EBITDA of its major private portfolio companies of 73 million GEL for Q1 2026, an increase of 26.9% year-on-year, with revenue up 13.7%. NAV per share remained largely stable in the quarter at 154.82 GEL, but due to a strong share price rise in Lion Finance Group up to 27 April 2026, NAV in GEL has increased 9.2% since the start of the year. The pharmacy business reinforced its market leadership with 244 million GEL in revenue, higher gross margin and an EBITDA margin of 11.9%; the holding shows a strong liquidity position and low net debt. Georgia Capital has so far deployed around 550 million GEL of the ongoing 700 million-GEL capital return program, expects dividend inflows of over 200 million GEL for 2026 and maintains a positive outlook. » Altro su de.investing.com
Georgia Capital reports NAV growth, extensive share buyback program and expansion in pharmacy sector
Georgia Capital recorded NAV growth of more than 9% year-to-date in Q1 2026 (in GEL +2.1%), with a total portfolio value of around 5 billion GEL. The company repurchased more than one-third of outstanding shares under a buyback program and opened 42 new retail pharmacies; outpatient revenues in the healthcare segment rose 17%. Healthcare services EBITDA was 27 million GEL (+16%), the property and casualty insurance business increased profits by 27%, and management provided 2026 EPS and revenue guidance as well as expected dividend inflows of over 200 million GEL. » Altro su de.investing.com
Georgia Capital: net asset value rises 61% in 2025, capital returns accelerated
Georgia Capital reports a 61.2% increase in net asset value per share in lari for 2025 and a NAV of 154.68 GEL as of 31.12.2025 (further to 162.61 GEL since 30.09.2025). Aggregate EBITDA of large unlisted holdings grew 28.6% in 2025; free cash flow rose to $65m (+52.3% per share). The company completed a $50m share buyback, has returned $246m in capital since 2018 and is using a new return program of 700m GEL through end-2027 (about ~550m GEL deployed by Feb. 2026). Management and analysts highlight strong profitability, balance sheet optimisation (net debt/EBITDA 3.7x) and continued growth plans in the pharmacy, insurance and healthcare segments. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | giugno 2026 | YoY |
|---|---|---|
| Ricavi | 246,27 Mln | - |
| Utile lordo | 246,27 Mln | - |
| Utile netto | 244,33 Mln | - |
| EBITDA | 0 | - |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 1,94 Mld € |
Numero di azioni | 32,85 Mln |
Massimo/minimo a 52 settimane | 61,22 € - 29,29 € |
| Dividendi | No |
Beta | 0,67 |
Rapporto P/E | 0,80 |
Rapporto PEG | 0,00 |
Rapporto P/B | 0,27 |
Rapporto P/S | 0,97 |
Profilo aziendale
Georgia Capital PLC è una società di private equity e venture capital specializzata in investimenti in aziende nelle fasi iniziale, di crescita organica e di acquisizioni. Prende in considerazione aziende dalle fasi greenfield fino a quelle mature. La società investe tipicamente nel settore del commercio al dettaglio di automobili, nei servizi educativi, negli hotel, nei resort e nelle compagnie di crociera, nei ristoranti, nelle bevande, nella sanità, nelle banche, nelle assicurazioni di danni a beni e responsabilità civile, nelle assicurazioni sulla vita e sulla salute, nella pubblicità, nei REIT diversificati, nelle utility idriche e nell'elettricità da fonti rinnovabili. Mira a investire in Georgia. La società cerca di ottenere un posto nel consiglio di amministrazione di società di portafoglio quotate in borsa. Disinveste tramite IPO o cessione a un investitore industriale entro cinque-dieci anni. La società raccoglie capitale attraverso operazioni sul mercato azionario e su quello obbligazionario. Georgia Capital PLC è stata fondata nel 2018 e ha sede a Tbilisi, in Georgia, con un ufficio aggiuntivo a Londra, Greater London e Bristol, nel Regno Unito. Georgia Capital PLC opera in modo indipendente da BGEO Group plc a partire dal 29 maggio 2018.
| Nome | GEORGIA CAPITAL LS 0,01 |
| CEO | Irakli Gilauri |
| Sede centrale | Tbilisi,
Regno Unito |
| Sito web | |
| Quotazione in borsa | 20/12/2012 |
| Dipendenti | 20.284 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
London Stock Exchange | CGEO.L |
Pnk | GRGCF |
Frankfurt | 2IX.F |
Düsseldorf | 2IX.DU |
London | CGEO.L |
München | 2IX.MU |